Test 2 OB Complications/Management Flashcards
The 3 significant risk factors for preterm
- History of preterm labor
- Non-Hispanic black race
- Multiple gestation
- Side effects of f terbutaline 5
-
Side effects of f terbutaline
- hypotension
- tachycardia
- pulmonary edema
- hyperglycemia
- hypokalemia
Factors assoc. with Breech Presentation:
Main 4:
Factors assoc. with Breech Presentation:
Main 4:
- Uterine distention or relaxation
- Abnormalities of uterus or pelvis
- Abnormalities of fetus
- OB conditions
Factors assoc. with Breech Presentation:
These may cause: Uterine distention or relaxation:
- multiparity
- multiple gestation
- macrosomia
- hydramnios
Factors assoc. with Breech Presentation:
These may cause: Abnormalities of uterus or pelvis
- Pelvic tumors; contractures
- Uterine anomalies
Factors assoc. with Breech Presentation:
Abnormalities of fetus
- Hydrocephalus
- Anencephaly
Factors assoc. with Breech Presentation:
OB conditions
- Previous breech delivery
- Preterm
- Oligohydramnios
- Cornual-fundal placenta
- Previa
Fetal complications assoc with multiple gestation
- preterm delivery
- congenital anomalies
- polyhydramnios
- cord entanglement
- cord prolapse
- fetal growth restriction
- twin to twin transfusion
- malpresentation
Maternalcomplications assoc with multiple gestation
- pPROM
- preterm labor
- prolonged labor
- pre-eclampsia/eclampsia
- DIC
- forceps/csec
- uterine atony
- OB trauma
- ante/post partum hemorrhage
most common medical disorder of pregnancy:
effects 6-10%
gestational cause: 5%
HTN
No proteinuria with HTN ,may consider Pre-eclamptic if any of following are present
- No proteinuria with HTN ,may consider Pre-eclamptic if any of following are present
- 1) persistent epigastric or RUQ pain
- 2) persistent cerebral symptoms
- 3) fetal growth restriction
- 4) thrombocytopenia
- 5) elevated liver enzymes
-
Chronic hypertension with superimposed preeclampsia
- Will menifest how?
- will see New onset proteinuria
- or sudden INC in proteinuria or hypertension or both
- Pre-eclampsia w/o severe features includes what parameters for each:
- BP
- Proteinuria
- protein - Cr ratio
- dip stick urine
- BP >140/90
- Proteinuria >/= 300mg/24h
- protein - Cr ratio >/= 0.3
- dip stick urine 1+ protein
Diagnostic criteria for SEVERE Pre-eclampsia
- BP > 160/110
- plt < 100k
- Cr > 1.1 or > 2x baseline
- pulm edemer
- new onset cerebral/visual disturbance
- impair liver fx
Pre-eclampsia: symptoms
CNS
- severe HA,
- hyperexcitability
- hyperreflexia
- coma
- visual disturbances (scotoma, amaurosis, & blurred vision)
Pre-eclampsia: symptoms
Airway
- pharyngolaryngeal edema
- subglottic edema (made worse with preeclampsia)
- Dysphonia, stridor, hoarseness, snoring, and hypoxemia are s/s of airway swelling
Pre-eclampsia: symptoms
Pulmonary
- INC colloid osmotic pressure + INC vascular permeability & loss of intravascular fluid & protein into interstitium = pulmonary edema
Pre-eclampsia: symptoms
CV
- hypertension
- vasospasm
- end-organ ischemia
- hyperdynamic state ( INC CO, hyperdynamic LV function, INC SVR) – exaggerated response to circulating catecholamines
Pre-eclampsia: symptoms
Hematology
- thrombocytopenia (most common hematologic abnormality);
- platelet counts < 100,000 mm3 seen in severe stages & in HELLP DIC can occur if severe liver involvement
- intrauterine fetal demise
- placenta abruption
-
postpartum hemorrhage
- Disease state can begin with hypercoagulability but progresses to hypocoagulability
Therapeutic range for serum Mg level:
mg/dLs
mEq/L
- Therapeutic range for serum Mg level:
- 5-9 mg/dLs (Chestnut’s)
- 4-6 mEq/L (M&M)
-
Hypermagnesemia: changes with these levels
- 12 mg/dL
- 15-20 mg/dL
- > 25 mg/dL
-
Hypermagnesemia: when pass therapeutic levels and get toxic
- 12 mg/dL Patellar reflexes lost i(deally stop gtt at this time)
- 15-20 mg/dL Respiratory arrest
- > 25 mg/dL Asystole
GA: indications in Preeclampsia
- GA: indications in Preeclampsia
- severe maternal hemorrhage
- fetal bradycardia
- severe thrombocytopenia &/or coagulopathy
-
Placenta Previa (cont)
- Classic sign:
-
Placenta Previa (cont)
- Classic sign:
- Painless vaginal bleeding 2nd or 3rd trimester
- Classic sign:
-
Anesthetic management: Previa
- Technique depends on: 3
-
Anesthetic management
- Technique depends on:
- indication & urgency of delivery
- severity of maternal hypovolemia
- obstetric history
- Technique depends on:
most common cause of maternal mortality
obstetric hemorrhage is the most common cause of maternal mortality and postpartum hemorrhage contributes to 80% of that.
Major risk factors for VTE in PP period: need at least one of these to be able to be put on anticoagulation
- immobility (strict bed rest >= week during antepartum
- previous VTE
- Preeclampsia w/ fetal growth restriction
- Thrombophilia
- AT III def
- Fact V leiden (homo or heterozygous)
- PT G20210A “ “
- Medical
- SLE
- HD
- Sickle cell
- PP hemorrhage >= 1000ml and surgery
- PP infection
- Blood tx
Minor risk factors for VTE in PP period: need at least two of these to be able to be put on anticoagulation
- BMI > 30 kg/m2 (Obesity)
- Csec (E)
- multiple pregnancy
- PP hemorrhage > 1000 ml
- Smoking > 10 cig/day
- Fetal growth restriction
- Thrombophilia
- Protein C or Protein S deficiency
- Preeclampsia
Uterine artery/blood supply
Chronic BF reduction – usually due to:
- abnormal placental development
- maternal disease (preeclampsia)
- In pregnancy, flow may differ between R & L uterine arteries
- In the uterine arteries (compared with contralateral artery):
- Vessel diameter is __ greater (on side of placenta)
- Blood flow is ___greater (on side of placenta)
- In the uterine arteries (compared with contralateral artery):
- In pregnancy, flow may differ between R & L uterine arteries
- In the uterine arteries (compared with contralateral artery):
- Vessel diameter is ~ 11% greater (on side of placenta)
- Blood flow is ~ 18% greater (on side of placenta)
- In the uterine arteries (compared with contralateral artery):
uterine BF increases during pregnancy
3 phases of increase:
- 1) before & during implantation & early placentation
- 2) growth & remodeling of uteroplacental vasculature
- 3) progressive uterine artery vasodilation to meet fetal needs
- 3 major factors that decrease UBF:
1) hypotension
2) vasoconstriction (uterine)
3) contraction (uterine)
- Common causes of hypotension during pregnancy
- ACC
- Hypovolemia
- Sympathetic blockade w/ NAA
use UPP, UVR, UAP and UAP to make 2 formulas for UBF:
- Uterine blood flow =
- Uterine blood flow =
- Uterine blood flow = UPP/UVR
- Uterine blood flow = (UAP – UVP)/ UVR
- Embryonic placenta circulation begins about __weeks gestation
- about 8 weeks gestation
- Mature placenta:
- Ave diameter __ cm
- Weight __ g
- Thickness__ mm
- At term, fetal-placental weight is __% of maternal wt
- Mature placenta:
- Ave diameter 18.5 cm
- Weight 500 g
- Thickness 23 mm
- At term, fetal-placental weight is 6% of maternal wt
where most of the placental exchange of nutrients, gases and wastes occur.
terminal villi - where most of the placental exchange of nutrients, gases and wastes occur.
-
UBF at term:
- Max __ ml/min (~ 10% CO)
- __ ml/min to myometrium
- __ ml/min to decidua
- Remainder to intervillous space ~ __% UBF
- Max __ ml/min (~ 10% CO)
-
UBF at term:
- Max 700-900 ml/min (~ 10% CO)
- 150 ml/min to myometrium
- 100 ml/min to decidua
- Remainder to intervillous space ~ 80% UBF
- Max 700-900 ml/min (~ 10% CO)
- Passive Transport Depends on:
- concentration & electrochemical difference
- molecular weight
- lipid solubility
- degree of ionization
- membrane surface area & thickness
Things that make facilitated transport different from passive transport: Facilitated involves these: 4
1) Saturation kinetics
2) Competitive & noncompetitive inhibition
3) Stereospecificity
4) Temperature influences – a higher temp will result in a greater transfer
- Other Factors Influencing Placental Transport
- Maternal & fetal blood flow
- placental binding
- placental metabolism
- diffusion capacity
- maternal & fetal plasma protein binding
- gestational age
- lipid solubility
- pH gradients
- plasma protein levels
- disease states
- Uterine blood flow is about ___**mL/minute
- Uterine cord blood flow is about ___ mL/minute
- Uterine blood flow is about 700 mL/minute
- Uterine cord blood flow is about 300 mL/minute
-
Oxygen
- Placenta provides ___ml O2/min/kg fetal body weight—it acts as the lung for the fetus; however:
-
Oxygen
- Placenta provides 8 ml O2/min/kg fetal body weight—it acts as the lung for the fetus; however:
- Transfer of Respiratory Gases & Nutrients
-
Carbon Dioxide
- Transfer occurs through several forms:
- dissolved CO2
- carbonic acid
- bicarbonate ion
- carbonate ion
- carbaminohemoglobin
- Concentration of amino acids is highest in this order: (highest to lowest)
- Concentration of amino acids is highest in this order: (highest to lowest)
- Placenta
- umbilicus venous blood (Umbilical vein)
- maternal blood
what determines the fetus’s exposure to drugs that the mother has received.
Placental permeability and pharmacokinetics
-
Drug Transfer
- Factors affecting drug transfer across the placenta:
- lipid solubility
- protein binding
- tissue binding
- pKa
- pH
- blood flow
- Rate of diffusion (Drug Transfer) depends on:
- Maternal-to-fetal concentration gradient
- maternal protein binding
- molecular wt of substance
- lipid solubility
- degree of ionization of substance
- placental properties
- hemodynamic events within the fetomaternal unit
- Maternal blood concentration of a drug is typically the primary determinant of how much drug will ultimately reach the fetus. Factors that effect this are:
- Dose
- Mode and Site of administration
- Additive drugs (ex- epinephrine added to a local)
- Transfer of drugs from maternal circulation to the fetal unit is determined primarily by diffusion.
- Factors favoring diffusion include:
- Low molecular weight
- High lipid solubility
- Low degree of ionization
- Low protein binding
factors that minimize drug effects on fetus
- Dilution
- fetal cardiac output
- acid base status of fetus
Extremely high levels of local, such as those with unintended maternal intravascular injection, can cause:
- fetal bradycardia,
- ventricular arrhythmias
- acidosis
- severe cardiac depression
Roles of Amnio fluid
1) Facilitates fetal growth
2) Provides of microgravity environment that cushions fetus
3) Generates defense mechanism against invading microorganisms
Amniotic fluid
- Between 10 & 20 weeks, volume increases from ~ __ to __
- Between 10 & 20 weeks, volume inc from ~ 25 ml to 400 ml
Amnio fluid
- Near term fetal urine production is __ mL/ day, respiratory tract __ mL/kg fetal body weight/day, and swallowing is __ml/kg fetal body weight/day
- Near term fetal urine production is 600-1200 mL/ day, respiratory tract 60-100 mL/kg fetal body weight/day, and swallowing is 200-250 ml/kg fetal body weight/day
amnio fluid
- b/w amniotic fluid and fetal blood w/in placenta
- b/w amniotic fluid and maternal blood within the uterus
- intramembranous - b/w amniotic fluid and fetal blood w/in placenta
- transmembranous - b/w amniotic fluid and maternal blood within the uterus
Amniotic Fluid
-
Composition
- Keratinization + fetal production of urine results in:
Amniotic Fluid
-
Composition
- Keratinization + fetal production of urine results in:
- urea & creatinine
- Na+ & Cl-
- osmolality
- Keratinization + fetal production of urine results in: